FDA Investigator Thomas W Gordon
Thomas W Gordon has conducted inspections on 713 sites in 11 countries as of 27 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
713
Last Inspection Date:
27 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Argentina,
United States of America,
China,
Germany,
United Kingdom of Great Britain and Northern Ireland,
Serbia,
India,
Canada,
Poland,
Netherlands,
Sweden
FDA Investigators that have inspected at least one site in common with Thomas W Gordon:
Alan L Truong,
Alanna L Mussawwir Bias,
Alex G Kalugin,
Amanda E Lewin, PhD,
Andrew E Kay,
Angela D Wise,
Anh M Lac,
Anna L Marroquin,
Annie H Lam,
Anthony E Keller, RPh,
Anthony N Onianwa,
Arindam Dasgupta, PhD,
Ashar P Parikh,
Azza Talaat,
Barbara J Rincon,
Brian P Putz,
Bruce H Mccullough,
Carl Lee,
Carla J Lundi,
CDR Rochelle B Young, RPh, MSA,
Charles D Brown,
Christopher J Lee,
Christopher M Reed,
Cindy W Lewis,
Claudia Mperez Kasmarski,
Clinton J Lott,
Courtney N Long,
Courtney R Bolton,
Cynthia L Evitt,
Damon A Growl,
Daniel J Roberts,
Daniel L Aisen,
Darla R Bracy,
Darlene B Almogela,
Darneillej,
David A Lum,
David G Eng,
David H Engelskirchen,
David X Gan,
Dejon N Harris,
Dena L Jacobs,
Deyaa Shaheen,
Dustin P Tran,
Elva M Ibarra,
Emmanuel O Kerry,
Eric W Anderson,
Erica L Nicoll,
Estefania Fernandez,
Gajendiran Mahadevan, PhD,
Garciam,
Gerald N Mcgirl, DDS,
Gulshan R Anand,
Gunneet Kaur,
Hasan A Irier, PhD,
Helen J Hamaoka,
Humberto Z Gomez,
Ingrid A Zambrana,
Ismael Garibay,
Ivis L Negron,
Jacobitz,
James A Barreto,
James A Liubicich,
James C Yee,
James W Whitney,
Jamie L Port,
Jane M Kreis,
Janete F Guardia,
Janice K Gardner,
Jazmine M Welcher,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer Crumb,
Jennifer L Degroot,
Jennifer L Johnson,
Jennifer S King,
Jessica B Darneille,
Joanne Hosting,
Joanne M Fukuda,
Joanne M Schlossin,
John A Gonzalez,
Jonathan M Mcbride,
Jorge L Bertran,
Jose M Cayuela,
Joseph M Willems,
Joseph P Iser, MD,
Joseph R Haynes,
Joseph Tibay,
Joshua C Schafer,
Joy P Matthias,
Julia N Alvarez,
Julia Ventura,
Kara D Dobbin,
Karen J Bak,
Karen L Robles,
Karen M Willis,
Karin A Velasques,
Karla J Gibler,
Kathleen D Culver,
Katie T Duong,
Kawshalya Pathiraja,
Kelly S Mammen,
Kelvin X Sanders,
Kenneth G Klobus,
Kenneth S Boehnen,
Kent A Conforti,
Kevin P Foley,
Lacresha Menifee,
Lam,
Lance Mde Souza, MBA,
Ligia M Cline,
Ligia M Sanders,
Lillian C Lopez,
Linda S Shook,
Lisa H Nakagawa,
Lisa K Capron,
Lloyd D Payne,
Lopez,
LT Mark A Chen, MPH,
Lucas B Leake,
Lucila B Nwatu,
Lynda L Perry, PhD,
Macropolk,
Maira P Brading,
Makini Cobourne Duval, PhD,
Marcus F Yambot,
Marie A Fadden,
Marie K Kinkade,
Marjorie D Santos,
Mark C Saale,
Mark E Baldwin,
Marshalette O Edwards,
Mary C Acton,
Matthew C Watson,
Matthew R Clabeaux,
Mcgrewp,
Melody M Ragasa Leong,
Michael D Garcia,
Michael S Call,
Michele M Falchek,
Michelle L Lopez,
Michelle L Orner,
Minh D Phan,
Monique C Lo,
Mra Mcculloughj,
Myers,
Ngoc T Le,
Nicholas L Hunt,
Nicolas C Tolosa, III,
Nicole Yuen,
Phal K Chhun,
Phillip J Sample,
Randy L Elsberry,
Regina T Brown,
Richard H Penta,
Robert D Tollefsen,
Robles,
Rochelle A Rolnik,
Rochelle R Blair,
Ronald P Boyce,
Ruben C Ayala, PharmD,
Rumany C Penn, PharmD,
Sajin Bae,
Samuel J Barone, III,
Sandra S Saniga,
Sangeeta M Khurana, PhD,
Sara H Gabel,
Sara Jdent Acosta,
Satheesh Thomas,
Savannah E Samp,
Scott J Matsuda,
Scott N Lim,
Shaquenta Y Perkins,
Shelby N Turner,
Shelly M King,
Simone E Pitts,
Siobhan A Gallagher,
Sondra R Davis,
Sparky L Bartee,
Sripal R Mada, PhD,
Stefanie R Cook,
Steven A Gonzales,
Steven D Kehoe,
Steven E Porter, Jr,
Steven M Galvez,
Stuart W Russell,
Taichun Qin, PhD,
Tammy Vasquez Hancock,
Theressa B Smith,
Tiffani D Wilson,
Timothy T Kapsala,
Tomanik'e C Banks,
Travelle D Mason,
Travis R Hunt,
Tristian E Strait,
Tuan D Tran,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Victoria Taylor,
Willemsj,
William V Millar,
Xikui Chen (nmi), PhD,
Yen Tso Kuo
Thomas W Gordon's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more